Identification of a novel mutation at the primary dimer interface of GyrA conferring fluoroquinolone resistance in Clostridium difficile
Micheál Mac Aogáin(Nanyang Technological University), Thomas R. Rogers(Scripps Research Institute), Geraldine Moloney(Trinity College Dublin), Trefor Morris(University Hospital of Wales), Shauna Kilkenny(Trinity College Dublin), Sinéad Lindsay(Trinity College Dublin), Claire Walsh(Trinity College Dublin), Sophie Jones(University Hospital of Wales)
Cited by 14
Related Papers
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion
|Intensive Care Medicine|2020|464
Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology
|The Lancet Infectious Diseases|2021|450
International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections
|Clinical Infectious Diseases|1997|426
Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study
|The Lancet Respiratory Medicine|2015|336